Back to Capital Research Global Investors Capital Research Global Investors

HCATHCAT
16 quarters

Position history for Capital Research Global InvestorsCapital Research Global Investors's holdings in HEALTH CATALYST INC

Capital Research Global Investors previously held 0 shares of HCAT (HEALTH CATALYST INC), worth $0 as of 2023-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$7.1M

Total Shares Change

-223,100

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2023-Q2
Latest
Exited
0
-100.0%
$00.0%$12.30
0
2023-Q1
Unchanged
568,785
0.0%
$6.6M0.0%$11.38
0
2022-Q4
Unchanged
568,785
0.0%
$6M0.0%$10.63
0
2022-Q3
Unchanged
568,785
0.0%
$5.5M0.0%$10.17
0
2022-Q2
Decreased
568,785
-83.2%
$8.2M0.0%$15.52
0
2022-Q1
Unchanged
3.4M
0.0%
$88.6M0.0%$26.62
0
2021-Q4
Increased
3.4M
+8.8%
$134.4M0.0%$40.56
33
2021-Q3
Increased
3.1M
+0.9%
$155.8M0.0%$50.13
31
2021-Q2
Increased
3.1M
+3.2%
$171.5M0.0%$55.98
31
2021-Q1
Increased
3M
+3.9%
$140M0.0%$46.28
31
2020-Q4
Unchanged
2.9M
0.0%
$125.5M0.0%$43.25
0
2020-Q3
Increased
2.9M
+92.7%
$105.5M0.0%$36.77
48
2020-Q2
Increased
1.5M
+662.6%
$43.6M0.0%$27.60
47
2020-Q1
Unchanged
196,200
0.0%
$5.1M0.0%$25.48
0
2019-Q4
Decreased
196,200
-12.1%
$6.8M0.0%$34.12
0
2019-Q3
New
223,100
-
$7.1M0.0%$30.31
38

Other major holders of HCAT: SC US (TTGP), LTD., ALLIANCEBERNSTEIN L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used